Knowledge Hub
Category: Global initiatives - Disease: Tuberculosis -
Plenary presentation
HIV – Kathryn Mngadi (Caprisa/HVTN), Punee Pitisittithum (Mahidol University); TB – Gerald Voss (Global HIV Vaccine Enterprise), Willem Hanekom (BMGF); Malaria – Fred Binka (University of...
Strategic intent for Preferred Policy Profiles and proposed test cases
Recent results in TB vaccine R&D are game-changing: what key challenges and opportunities remain?
0:05 - Opportunities, risks, and potential valleys of death, David Kaslow, PATH. 16:22 - Is there a role for early policy decision? Rino Rappuoli, GSK. 27:58 - Building the concept of Preferred...